Haoxi Health Technology (NASDAQ: HAO) is a China-based healthcare technology company focused on the development and provision of digital solutions for medical imaging and health management. Since its founding in the early 2010s, the company has pursued a mission to enhance the efficiency and quality of health screenings and diagnostic processes. Haoxi Health went public on the Nasdaq Stock Market, leveraging its proprietary software platforms and strategic partnerships to expand its footprint across the Chinese healthcare sector.
The core of Haoxi Health’s offering lies in its cloud-based Health Management Platform, which integrates electronic health records, picture archiving and communication systems (PACS), and advanced data analytics. This platform is designed to streamline workflows in hospitals, community health centers, and private physical examination clinics. Key software modules support tasks such as appointment scheduling, report generation, image storage and retrieval, and remote consultations. The company’s solutions are sold under a subscription-based model, enabling clients to adopt scalable, pay-as-you-go technology without heavy upfront investments.
In addition to its SaaS products, Haoxi Health provides on-site implementation services, training programs, and ongoing technical support. Its professional services team works closely with clients to customize system configurations, integrate with existing hospital information systems (HIS), and comply with local regulatory standards. The company also engages in research and development to enhance its artificial intelligence capabilities, aiming to offer computer-aided detection and diagnostic assistance for radiologists and clinicians.
Headquartered in Beijing, Haoxi Health serves a wide geography spanning more than 20 provinces and municipalities in China, including first-tier cities as well as underserved regional markets. The management team is led by its founder and chief executive officer, who brings over 15 years of experience in healthcare IT, supported by executives with backgrounds in medical device manufacturing, software engineering, and hospital administration. Together, they are committed to driving digital transformation in China’s healthcare industry and exploring opportunities for future expansion into adjacent markets.
AI Generated. May Contain Errors.
Free HAO Stock Alerts